Christopher Scott - Perimeter Medical Chief Officer
PINK Stock | CAD 0.41 0.01 2.50% |
Insider
Christopher Scott is Chief Officer of Perimeter Medical Imaging
Age | 54 |
Address | 555 Richmond Street West, Toronto, ON, Canada, M5V 3B1 |
Phone | 214-845-5154 |
Web | https://perimetermed.com |
Christopher Scott Latest Insider Activity
Tracking and analyzing the buying and selling activities of Christopher Scott against Perimeter Medical stock is an integral part of due diligence when investing in Perimeter Medical. Christopher Scott insider activity provides valuable insight into whether Perimeter Medical is net buyers or sellers over its current business cycle. Note, Perimeter Medical insiders must abide by specific rules, including filing SEC forms every time they buy or sell Perimeter Medical'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Christopher Scott over six months ago Disposition of 1171 shares by Christopher Scott of Matson at 107.83 subject to Rule 16b-3 |
Perimeter Medical Management Efficiency
The company has return on total asset (ROA) of (0.5935) % which means that it has lost $0.5935 on every $100 spent on assets. This is way below average. Similarly, it shows a return on equity (ROE) of (0.7706) %, meaning that it generated substantial loss on money invested by shareholders. Perimeter Medical's management efficiency ratios could be used to measure how well Perimeter Medical manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to -0.73 in 2024. Return On Capital Employed is likely to climb to -0.98 in 2024. At this time, Perimeter Medical's Net Tangible Assets are fairly stable compared to the past year. Fixed Asset Turnover is likely to climb to 0.11 in 2024, whereas Total Assets are likely to drop slightly above 19.2 M in 2024.Similar Executives
Found 13 records | INSIDER Age | ||
Luc Olivier | KDA Group | N/A | |
Kent Stout | Altagas Cum Red | N/A | |
Phillip Burns | European Residential Real | 55 | |
Randall Crawford | Altagas Cum Red | 60 | |
Joy Thakur | Altagas Cum Red | N/A | |
James Shelford | Altagas Cum Red | 39 | |
JeanMarc Leveille | KDA Group | N/A | |
Corine Bushfield | Altagas Cum Red | 48 | |
Giuseppe DAprano | KDA Group | N/A | |
JeanPierre BSc | KDA Group | N/A | |
Jenny Chou | European Residential Real | N/A | |
Esq BComm | Altagas Cum Red | N/A | |
Jon Morrison | Altagas Cum Red | N/A |
Management Performance
Return On Equity | -0.77 | ||||
Return On Asset | -0.59 |
Perimeter Medical Imaging Leadership Team
Elected by the shareholders, the Perimeter Medical's board of directors comprises two types of representatives: Perimeter Medical inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Perimeter. The board's role is to monitor Perimeter Medical's management team and ensure that shareholders' interests are well served. Perimeter Medical's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Perimeter Medical's outside directors are responsible for providing unbiased perspectives on the board's policies.
Merle Boon, Chief Officer | ||
Rochelle Keen, Head Programs | ||
Adam Hodges, Vice Marketing | ||
Stephen Kilmer, Investor Officer | ||
Christopher Scott, Chief Officer | ||
Vladimir Pekar, Head Devel | ||
Adrian Mendes, CEO Director | ||
Jeremy Sobotta, Pres CEO | ||
Andrew Berkeley, CoFounder Officer | ||
Steve Sapot, Chief Officer | ||
Sara Brien, Chief Officer |
Perimeter Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Perimeter Medical a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
Return On Equity | -0.77 | ||||
Return On Asset | -0.59 | ||||
Operating Margin | (20.51) % | ||||
Current Valuation | 24.4 M | ||||
Shares Outstanding | 93.38 M | ||||
Shares Owned By Insiders | 13.30 % | ||||
Shares Owned By Institutions | 33.22 % | ||||
Number Of Shares Shorted | 4.18 K | ||||
Price To Book | 2.07 X | ||||
Price To Sales | 55.23 X |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Perimeter Stock Analysis
When running Perimeter Medical's price analysis, check to measure Perimeter Medical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Perimeter Medical is operating at the current time. Most of Perimeter Medical's value examination focuses on studying past and present price action to predict the probability of Perimeter Medical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Perimeter Medical's price. Additionally, you may evaluate how the addition of Perimeter Medical to your portfolios can decrease your overall portfolio volatility.